Merck Sharp Dohme Llc

Average Safety Score: 83/100 · Critical

2 drugs in portfolio

Drugs by Merck Sharp Dohme Llc

PEMBROLIZUMAB — 88/100 · Critical
SITAGLIPTIN — 78/100 · Elevated

Disclaimer: Based on FDA adverse event reports. Not medical advice.